Language: | Slovenian |
---|---|
Year of publishing: | 2022 |
Typology: | 1.08 - Published Scientific Conference Contribution |
Organization: | OI - Institute of Oncology |
Publisher: | Onkološki inštitut |
UDC: | 616.3 |
COBISS: |
135699715
![]() |
Parent publication: | Tumorji prebavil |
Views: | 55 |
Downloads: | 22 |
Average score: | 0 (0 votes) |
Metadata: |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
Secondary language: | English |
---|---|
Secondary title: | D3 lymphadenectomy in right hemicolectomy |
Secondary abstract: | Surgical treatment is indicated for resectable colon cancer. The aim of this treatment is the radical removal of the tumor with a vascular stalk according to the principle of complete mesocolic excision. For right hemicolectomy, which is a standard operation for cancer of the appendix, cecum and ascending colon, D3 lymphadenectomy has been performed in the last decade. Some studies have shown that D3 compared to D2 lymphadenectomy allowed longer disease-free survival. Some Asian countries have already introduced D3 lymphadenectomy among the recommendations for the surgical treatment of colon cancer. Nevertheless, there is not enough solid evidence to adopt similar guidelines elsewhere in the world. |
Source comment: | Nasl. z nasl. zaslona; Opis vira z dne 29. 12. 2022; |
Pages: | Str. 93-96 |
ID: | 17732096 |